Bio-Techne Corporation
Bio-Techne Corporation (TECH) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · TECH · as of Mar 31, 2025
Ownership Breakdown
587
Institutional Holders
▲ 2 vs Q4
$9.52B
Total Inst. Value
▼ $1.78B vs Q4
156.57M
Shares Outstanding
freeFloat 99.61%
162.41M
13F Shares Held
▲ 5.63M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
TECH largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC biological products, (no diagnostic substances) | 18.53M | 11.77% | 11.77% | $1.09T | May 9, 2025 | ▼ 67.8K |
BLACKROCK, INC. biological products, (no diagnostic substances) | 13.75M | 8.73% | 8.73% | $805.95B | May 2, 2025 | ▼ 290.1K |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 11.38M | 7.23% | 7.23% | $666.93B | May 14, 2025 | ▲ 721.0K |
STATE STREET CORP biological products, (no diagnostic substances) | 6.53M | 4.15% | 4.15% | $382.85B | May 15, 2025 | ▲ 57.2K |
MORGAN STANLEY biological products, (no diagnostic substances) | 5.72M | 3.63% | 3.63% | $335.34B | May 15, 2025 | ▲ 961.0K |
SELECT EQUITY GROUP, L.P. biological products, (no diagnostic substances) | 5.37M | 3.41% | 3.41% | $314.61B | May 15, 2025 | ▲ 3.03M |
INVESCO LTD. biological products, (no diagnostic substances) | 4.19M | 2.66% | 2.66% | $245.67B | May 12, 2025 | ▲ 369.7K |
GEODE CAPITAL MANAGEMENT, LLC biological products, (no diagnostic substances) | 4.09M | 2.60% | 2.60% | $239.26B | May 13, 2025 | ▲ 92.1K |
AMERIPRISE FINANCIAL INC biological products, (no diagnostic substances) | 3.59M | 2.28% | 2.28% | $210.32B | May 14, 2025 | ▼ 1.12M |
BAMCO INC /NY/ biological products, (no diagnostic substances) | 3.28M | 2.08% | 2.08% | $192.06B | May 15, 2025 | ▼ 861.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
27
Increased
+10.02M shares2
New Positions
first time holders21
Decreased
−4.99M shares0
Sold Out
fully exitedNet shares change (top 50)
+5.02M
+10.02M / −4.99M
Net new holders
+8
2 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
TECH insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
10
Buy transactions
20
Sell transactions
0.50
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Crouse Steven C. President - Diag & Spatial Bi | Jun 2, 2026 | Tax Withhold | 216 | $49.77 | $10.8K | 6.8K | Form 4 ↗ |
Herr Amy E. director | May 8, 2026 | Sale | 6,636 | $48.28 | $320.4K | 200 | Form 4 ↗ |
Hippel James CFO | May 5, 2026 | Tax Withhold | 56,955 | $56.68 | $3.23M | 153.7K | Form 4 ↗ |
Bohnen Shane SVP - General Counsel | May 5, 2026 | Tax Withhold | 7,055 | $56.68 | $399.9K | 7.2K | Form 4 ↗ |
Kelderman Kim Chief Executive Officer | May 5, 2026 | Tax Withhold | 23,951 | $56.68 | $1.36M | 65.8K | Form 4 ↗ |
Crouse Steven C. President - Diag & Spatial Bi | May 1, 2026 | Tax Withhold | 311 | $55.02 | $17.1K | 6.3K | Form 4 ↗ |
Kelderman Kim Chief Executive Officer | Apr 22, 2026 | Tax Withhold | 1,363 | $58.58 | $79.8K | 63.1K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Bio-Techne Corporation (TECH) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.39%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Bio-Techne Corporation is VANGUARD GROUP INC, holding approximately 18.53 million shares — equal to 11.77% of outstanding shares — as of March 31, 2025.
A total of 587 institutional investors currently hold TECH stock, with a combined institutional value of approximately $9.52 billion as of the most recent 13F filing period.
Frequently asked questions
TECH ownershipBio-Techne Corporation (TECH) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is VANGUARD GROUP INC with a 11.77% stake. Company insiders hold 0.39%. Data sourced from SEC Form 13F as of March 31, 2025.